Pfizer’s (NYSE:PFE) CEO Dr. Albert Bourla acknowledged in a statement that he has COVID-19.
Bourla, who is 60, has received four doses of the Pfizer-BioNTech Comirnaty vaccine. He also has begun taking a course of the company’s antiviral Paxlovid.
The Pfizer CEO notes that symptoms to date have been very mild.
Pfizer’s revenue has soared during the pandemic, largely thanks to the Comirnaty COVID-19 vaccine. Last year, the vaccine almost doubled Pfizer’s revenue to roughly $81 billion in 2021, making it the largest pharma company.
Last week, Bourla noted in an earnings call that the company continues to be well-positioned in the pandemic.
“In the second quarter, we recorded the largest amount of quarterly sales in our history,” Bourla noted in a news release.
The company continues to develop updated COVID-19 vaccine boosters, which the company expects to be commercially available in the early fall.
In July, Pfizer and …